Growth fears leave Wall Street flat
Jul 30, 2010
Amgen, the world's largest biotechnology company, rose 2.2 per cent to $54.53 after reporting a better-than-expected second quarter profit. ...

Lowest Relative Performance in the Biotechnology Industry Detected in Shares ...
Jul 30, 2010
Below are the top five companies in the Biotechnology industry as measured by lowest relative performance. This analysis was based on ...

Generex Announces AGM Results
Jul 30, 2010
WORCESTER, Mass., Jul 30, 2010 (GlobeNewswire via COMTEX) -- Generex Biotechnology Corporation (NASDAQ:GNBT) (www.generex.com) today announced the results ...

Relatively Good Cash Flow Detected in Shares of Combinatorx in the ...
Jul 30, 2010
Below are the top five companies in the Biotechnology industry as measured by the price to cash flow ratio. Often companies with the lowest ...

Stock Alert for Generex Biotechnology Corp. (GNBT)(D*)
Jul 30, 2010
Generex Biotechnology Corp. (GNBT) is engaged in the research, development and commercialization of drug delivery systems and technologies. ...

Amgen 2Q net income slips on higher taxes
‎Jul 29, 2010‎
NEW YORK — Biotechnology company Amgen Inc. said Thursday that its second-quarter net income slipped 5 percent, mainly on higher taxes, but the results ...

WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
Jul 30, 2010
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. ...

Idaho Technology Issues License to DuPont Qualicon
Jul 30, 2010
The agreement, effective June 18, 2010, follows a series of intellectual property licensing agreements with a number of other biotechnology companies over ...

Alkermes officials see bigger paydays
Jul 30, 2010
The Waltham biotechnology company yesterday reported that David A. Broecker, who resigned as chief executive in September 2009, earned $6.3 million in total ...

Sanofi Mum on Genzyme as It Posts Higher Profit
‎Jul 29, 2010‎
Sanofi-Aventis, the French pharmaceutical company considering an $18.6 billion bid for the American biotechnology firm Genzyme, said profits jumped in the ...